| pubmed-article:6192223 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6192223 | lifeskim:mentions | umls-concept:C0013216 | lld:lifeskim |
| pubmed-article:6192223 | lifeskim:mentions | umls-concept:C1096063 | lld:lifeskim |
| pubmed-article:6192223 | lifeskim:mentions | umls-concept:C0205171 | lld:lifeskim |
| pubmed-article:6192223 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:6192223 | pubmed:dateCreated | 1983-9-23 | lld:pubmed |
| pubmed-article:6192223 | pubmed:abstractText | Single drug therapy with either phenytoin or primidone resulted in complete seizure control in 11 of 35 patients (31%) referred to an epilepsy clinic for treatment of uncontrolled chronic epilepsy with complex-partial seizures. Complete seizure control was associated with an increase in the mean plasma concentrations from 14 micrograms/ml to 23 micrograms/ml phenytoin and from 34 micrograms/ml to 40 micrograms/ml phenobarbitone with no change in the antiepileptic drug. Insufficiently low plasma concentrations of less than 11 micrograms/ml phenytoin or phenobarbitone were measured at the first visit in 14 patients (40%). Non-compliance was admitted by eight patients (23%). Optimum single drug therapy is of considerable clinical value in intractable epilepsy with complex-partial seizures. | lld:pubmed |
| pubmed-article:6192223 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6192223 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6192223 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6192223 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6192223 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6192223 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6192223 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6192223 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6192223 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6192223 | pubmed:issn | 0340-5354 | lld:pubmed |
| pubmed-article:6192223 | pubmed:author | pubmed-author:SchmidtDD | lld:pubmed |
| pubmed-article:6192223 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6192223 | pubmed:volume | 229 | lld:pubmed |
| pubmed-article:6192223 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6192223 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6192223 | pubmed:pagination | 221-6 | lld:pubmed |
| pubmed-article:6192223 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:6192223 | pubmed:meshHeading | pubmed-meshheading:6192223-... | lld:pubmed |
| pubmed-article:6192223 | pubmed:meshHeading | pubmed-meshheading:6192223-... | lld:pubmed |
| pubmed-article:6192223 | pubmed:meshHeading | pubmed-meshheading:6192223-... | lld:pubmed |
| pubmed-article:6192223 | pubmed:meshHeading | pubmed-meshheading:6192223-... | lld:pubmed |
| pubmed-article:6192223 | pubmed:meshHeading | pubmed-meshheading:6192223-... | lld:pubmed |
| pubmed-article:6192223 | pubmed:meshHeading | pubmed-meshheading:6192223-... | lld:pubmed |
| pubmed-article:6192223 | pubmed:meshHeading | pubmed-meshheading:6192223-... | lld:pubmed |
| pubmed-article:6192223 | pubmed:meshHeading | pubmed-meshheading:6192223-... | lld:pubmed |
| pubmed-article:6192223 | pubmed:meshHeading | pubmed-meshheading:6192223-... | lld:pubmed |
| pubmed-article:6192223 | pubmed:meshHeading | pubmed-meshheading:6192223-... | lld:pubmed |
| pubmed-article:6192223 | pubmed:meshHeading | pubmed-meshheading:6192223-... | lld:pubmed |
| pubmed-article:6192223 | pubmed:year | 1983 | lld:pubmed |
| pubmed-article:6192223 | pubmed:articleTitle | Single drug therapy for intractable epilepsy. | lld:pubmed |
| pubmed-article:6192223 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:6192223 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:6192223 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6192223 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:6192223 | lld:pubmed |
